Morphological and Mechanical Changes in Ovariectomized Rat Tibia with Treatments of Ibandronate and Parathyroid Hormone
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Osteoporosis is a debilitating disease affecting the elderly population, associated with compromised stability and reduced mobility of the bone. Osteoporosis is diagnosed as a condition when the measured bone mineral density (BMD) falls below 2.5 standard deviations of peak mass. However, BMD alone might not be enough to define the osteoporotic condition because it does not accounts on the micro-architectural changes in the bone trabeculae. Thus, this study aimed at studying the micro- architecural changes in trabeculae rich bone metaphysis of ovariectomized rat models in comparison with the conventional BMD measurements and the mechanical parameters. In this study, proximal tibiae of twenty-five female rats from four different groups (SHAM, OVX, IBAN and PTH) were evaluated using micro-CT, pQCT and three point bending tests. The micro-CT analysis showed that the deterioration of trabecular bone was significant during the first 6 weeks after OVX surgery. During the early stage of osteoporosis, the trabecular density decreased more rapidly than the cortical density. Morphological analysis showed that early administration of both ibandronate and parathyroid hormone has a beneficial effect on restoring the trabecular structures. Bone mechanical properties of treatment groups did not show significant difference, but followed the overall trend as morphological indices. The results suggest that early administration of either ibandronate or PTH is effective in restoring the trabecular bone loss caused by osteoporosis. However, larger-scale studies should be conducted to better understand the effect of both anti-resorptive and anabolic treatments in terms of morphological and mechanical properties.
Abstract
Osteoporosis is a debilitating disease affecting the elderly population, associated with compromised stability and reduced mobility of the bone. Osteoporosis is diagnosed as a condition when the measured bone mineral density (BMD) falls below 2.5 standard deviations of peak mass. However, BMD alone might not be enough to define the osteoporotic condition because it does not accounts on the micro-architectural changes in the bone trabeculae. Thus, this study aimed at studying the micro- architecural changes in trabeculae rich bone metaphysis of ovariectomized rat models in comparison with the conventional BMD measurements and the mechanical parameters. In this study, proximal tibiae of twenty-five female rats from four different groups (SHAM, OVX, IBAN and PTH) were evaluated using micro-CT, pQCT and three point bending tests. The micro-CT analysis showed that the deterioration of trabecular bone was significant during the first 6 weeks after OVX surgery. During the early stage of osteoporosis, the trabecular density decreased more rapidly than the cortical density. Morphological analysis showed that early administration of both ibandronate and parathyroid hormone has a beneficial effect on restoring the trabecular structures. Bone mechanical properties of treatment groups did not show significant difference, but followed the overall trend as morphological indices. The results suggest that early administration of either ibandronate or PTH is effective in restoring the trabecular bone loss caused by osteoporosis. However, larger-scale studies should be conducted to better understand the effect of both anti-resorptive and anabolic treatments in terms of morphological and mechanical properties.
참고문헌 (26)
- Altundag O, "Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis", Medical hypotheses, 63, pp.1010~1013 (2004)
- Gabet Y, "Intermittently administered parathyroid hormone 1-34 reverses bone loss and structural impairment in orchiectomized adult rats", Osteoporosis Int, 16, pp.1436~1443 (2005)
- Black DM, "The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis", N Engl J Med, 349, pp.1207~1215 (2003)
- Black DM, "One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis", N Engl J Med, 353, pp.555~565 (2005)
- Fleisch HT, "The bisphosphonate ibandronate, given daily as well as discontinuously, decreases bone resorption and increases calcium retention as assessed by 45Ca kinetics in the intact rat", Osteoporos Int, 6, pp.166~170 (1996)
- Laib A, "The Temporal Changes of Trabecular Architecture in Ovariectomized Rats Assessed by MicroCT", Osteoporos Int, 12, pp.936~941 (2001)
- Stürmer EK, "Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: Effect of estradiol, testosterone, and raloxifene", J Bone Miner Res, 21, pp.89~96 (2006)
- Wilkin TJ, "Bone densitometry is not a good predictor of hip fracture", BMJ, 323, pp.797~799 (2001)
- Cefalu CA, "Is bone mineral density predictive of fracture risk reduction?", Curr Med Res Opin, 20, pp.341~349 (2004)
- Kumasaka S, "Relationship between bone mineral density and bone stiffness in bone fracture", Oral Radiology, 21, pp.38~40 (2005)
- Watts N, "BMD change explains only a fraction of the observed fracture risk reduction in risendronate treated patients", Osteoporos Int, 11(Suppl 2), pp.203~ (2000)
- Allolio B, "Risk factors for hip fracture not related to bone mass and their therapeutic implications", Osteoporos Int, 9(Suppl 2), pp.9~16 (1999)
- El-Kaissi S, "Femoral neck geometry and hip fracture risk: the Geelong osteoporosis study", Osteoporos Int, 16, pp.1299~1303 (2005)
- Stuermer EK, "Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracturehealing model at the tibia in rat", Langenbecks Arch Surg, 395, pp.163~172 (2010)
- Stuermer EK, "Effect of testosterone, raloxifene and estrogen replacement on the microstructure and biomechanics of metaphyseal osteoporotic bones in orchiectomized male rats", World J Urol, 27, pp.547~555 (2009)
- Boyd SK, "Monitoring individual morphological changes over time in ovariectomized rats by in vivo microcomputed tomography", Bone, 39, pp.854~862 (2006)
- Barbier A, "The visualization and evaluation of bone architecture in the rat using three-dimensional X-Ray microcomputed tomography", J Bone Miner Metab, 17, pp.37~44 (1999)
- Mühlbauer RC, "BM 21.0955, a potent new bisphosphonate to inhibit bone resorption", J Bone Miner Res, 6, pp.1003~1011 (1991)
- Monier-Faugere MC, "A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogs", J Bone Miner Res, 8, pp.1345~1355 (1993)
- Monier-Faugere MC, "Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: effects on bone morphometry and mineral properties", J Bone Miner Res, 14, pp.1768~1778 (1999)
- Laib A, "3D micro-computed tomography of trabecular and cortical bone architecture with application to a rat model of immobilization osteoporosis", Med Biol Eng Comput, 38, pp.326~332 (2000)
- Campbell GM, "Signs of irreversible architectural changes occur early in the development of experimental osteoporosis as assessed by in vivo micro-CT", Osteoporos Int, 19, pp.1409~1419 (2008)
- Dempster DW, "Temporal changes in cancellous bone structure of rats immediately after ovariectomy", Bone, 16, pp.157~161 (1995)
- Lane NE, "The Effects of Synthetic Conjugated Estrogens, A (Cenestin) on Trabecular Bone Structure and Strength in the Ovariectomized Rat Model", Osteoporos Int, 13, pp.816~823 (2002)
- Wronski TJ, "Skeletal alterations in ovariectomized rats", Calcif Tissue Int, 37, pp.324~328 (1985)
- Faugere MC, "Calcitriol corrects bone loss induced by oophorectomy in rats", Am J Physiol, 250, pp.35~38 (1986)